Edition:
United States

Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

29.98USD
21 Feb 2017
Change (% chg)

$-0.41 (-1.35%)
Prev Close
$30.39
Open
$30.23
Day's High
$30.63
Day's Low
$29.56
Volume
220,313
Avg. Vol
462,842
52-wk High
$44.38
52-wk Low
$24.47

Select another date:

Fri, Jan 27 2017

BRIEF-Emergent BioSolutions receives German Federal Ministry of Health Approval of Building 55 for large-scale manufacturing of BioThrax

* Emergent BioSolutions receives German Federal Ministry of Health Approval of Building 55 for large-scale manufacturing of BioThrax

BRIEF-Aptevo Therapeutics receives $20 mln payment from Emergent Biosolutions

* Aptevo Therapeutics receives $20 million payment from Emergent Biosolutions

BRIEF-Emergent Biosolutions announces preliminary 2016 financial results

* Emergent Biosolutions announces preliminary 2016 financial results and provides 2017 financial outlook

BRIEF-Emergent Biosolutions Q3 adjusted EPS $0.58 from continuing operations

* Emergent biosolutions reports third quarter and nine months 2016 financial results

BRIEF-Emergent biosolutions provides update on biothrax procurement contract and discussions with CDC

* Emergent Biosolutions provides update on status of Biothrax procurement contract and discussions with CDC

BRIEF-Emergent awarded BARDA contract for advanced development of NuThrax

* Awarded BARDA contract for advanced development and delivery of NuThrax, a next generation anthrax vaccine, valued at up to $1.6 billion

Select another date:

More From Around the Web